DOCSLIB.ORG

Health Benefits of Soy and Soy Phytochemicals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Health Benefits of Soy and Soy Phytochemicals Review Article Page 1 of 9 Health benefits of soy and soy phytochemicals Haoqing Wu1*, Ziang Zhang2*, Haiqiu Huang3, Ziwei Li3 1Shanghai High School, Senior Two Class Seven, Shanghai 200231, China; 2Department of Plastic and Reconstructive Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; 3Shanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China Contributions: (I) Conception and design: H Huang, Z Li; (II) Administrative support: Z Zhang, H Huang, Z Li; (III) Provision of study materials or patients: H Huang; (IV) Collection and assembly of data: None; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. *These authors contributed equally to this work. Correspondence to: Ziwei Li. Shanghai Biotecan Pharmaceuticals Co., Ltd, First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai 201204, China. Email: [email protected]; Haiqiu Huang. Shanghai Biotecan Pharmaceuticals Co., Ltd, First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai 201204, China. Email: [email protected]. Abstract: Soy is an important commodity and a long-time staple food in eastern Asian countries. Recent research and clinical studies have provided ample evidence for the health benefits of soy and soy foods, which have also contributed to an increase in soy consumption among the Western population. The current mini- review aims to summarize the current knowledge of the health benefits of soy and soy phytochemicals, and their reported effects in preventing (I) cardiovascular disease, (II) obesity-related metabolic syndrome, (III) certain types of cancers, and (IV) other chronic diseases. In addition to the widely reported soy isoflavones, namely, genistein, daidzein, and glycitein, a novel group of soy phytoalexins, glyceollins, have also shown promising biological activities, such as insulinotropic, antiestrogenic, antiproliferative, antioxidation, anti- inflammation, and cholesterol-lowering effects. The elucidation of soy’s health benefits is an important part of promoting the consumption of soy as a functional food and the understanding of the mechanism of actions of soy and soy phytochemicals’ biological activities will provide further evidence for the optimized use for health promotion. Keywords: Soy; phytochemicals; glyceollins; health benefit Received: 09 August 2017; Accepted: 11 October 2017; Published: 31 October 2017. doi: 10.21037/amj.2017.10.04 View this article at: http://dx.doi.org/10.21037/amj.2017.10.04 Introduction U.S. consumers indicated that they are interested in soy foods specifically for the reported health benefits (6-8). Soy (Glycine max) is an important commodity in the world’s Therefore, science-based information on health-promoting food supply and economy (1). Soy consumption as a food effects of soy and soy phytochemicals is of great economic has a long history in Asian countries, such as China and and societal importance and can further promote the use of Korea (2), while the U. S. accounted for more than 30% of soy and soy phytochemicals. world production in 2013 (3). The popularity of soy foods in the west increased significantly after a 1999 decision by the U.S. Food and Drug Administration to allow Health benefits of soy health claim of soy protein’s protective effect against heart Protection against cardiovascular disease disease (4). The U.S. retail soy food industry grew from $1 billion in 1996 to $4.5 billion in 2013 (5). The nutritional/ Epidemiological studies have long linked soy consumption health promoting value of soy and soy food was the major to a reduced risk for cardiovascular disease, and soy protein, contributing factor for the increasing demand, as 26% of soy-derived isoflavones, and soy sterols have been studied as © AME Medical Journal. All rights reserved. amj.amegroups.com AME Med J 2017;2;162 Page 2 of 9 AME Medical Journal, 2017 the active components contributing to such effects (2,9-12). while higher concentrations (25–50 µM) enhanced A recent review identified soy proteins to be partially adipogenesis, showing a biphasic effect (24). However, responsible for the lipid-lowering effects of soy (10). It has evidence in animal models and in vitro study did not always also been suggested that isoflavones may act on the vascular apply well to human, which made it inconclusive whether tissue to improve circulation (12-14). consumption of soy will benefit the obese population. Human Soy’s cardiovascular protective effects were reviewed and clinical experiments did not show any decrease in body highlighted in a meta-analysis of 38 controlled clinical trials weight as expected, but improvements in blood lipids (24) in human subjects and the correlation between consumption or improvements in insulin resistance was observed (25). of soy and lipid levels (15). It was concluded that an average consumption of 47 g soy protein/day resulted in significant Protection against cancer decreases in total cholesterol (9.3%), LDL cholesterol (12.9%) and triglycerides (10.5%). On the other hand, in a Soy has also shown potential in reducing the risk of many more recent analysis, the Nutrition Committee of American types of cancer (26-29) and, among which, breast and Heart Association found a much smaller decrease in LDL prostate cancers are of particular interest due to their (3%) with 50 g soy protein consumption per day from sensitivity to sex steroid hormones. eight randomized trials and no apparent benefit in 14 other Despite the amount of effort from experimental and studies (9). The responses appeared to be highly dependent epidemiological studies, soy products’ effect in breast and on the cholesterol level of the subjects. The meta-analysis prostate cancer prevention or therapy is largely unresolved. performed by Anderson and colleagues recruited patients Epidemiological studies among Asian population had long who were strongly hyperlipidemic (total cholesterol connected the lower breast cancer incident with consumption >250 mg/dL). It was expected that extreme hyperlipidemia of soy products, which was usually attributed to soy would benefit from greater percentage reductions in isoflavones (30,31). Alongside the modest protective effects, total and LDL cholesterol. In contrast, the patients with concern has also been expressed that the estrogenic activity moderate or minor hyperlipidemia recruited in the later of soy isoflavones may lead to adverse effects on progression studies showed less response to the soy protein. and recurrence of breast cancer (32). On the other hand, One proposed mechanism of soy’s cardio-protective effects there were some reviews citing a number of human clinical results from the inhibition of LDL oxidation and reduction and epidemiological studies indicating no evidence of risk of the formation of plaque in the arteries. Soy extracts (16,17) in human (33-35). Preventative effect of soy against prostate and peptides (18,19) have both been shown to reduce the cancer have been reviewed previously (36) and clinical trials oxidation of LDL cholesterol in vitro and in vivo. It was also have also shown soy’s therapeutic effect against prostate reported that the anthocyanins found in color seed coat cancer (37,38), which, again, was challenged by another of soy displayed potent anti-oxidant properties and could intervention study that did not support that soy consumption inhibit LDL oxidation (16,20,21). A more recent hypothesis can benefit men with prostate cancer, while not excluding the involves the liver’s LDL receptors, which may be affected by possibility of soy’s effect in preventing prostate cancer (39). soy consumption to enhance their uptake of LDL from the Mechanisms of soy’s cancer prevention effects are serum and consequently lower serum LDL levels (22). attributable to the isoflavones. Previous studies suggested that multiple mechanisms of action may be responsible. Isoflavones have been shown to affect the cell cycle, Protection against obesity-related metabolic syndrome apoptosis, differentiation, proliferation, growth, along with The potential of soy consumption in mitigating obesity and effects on cell signaling (38,40,41). Isoflavones also exhibited related complications were reported in recent studies (23,24). antioxidant capacity. They are well-known scavengers for The exact efficacy is still under investigation. Mechanistically, reactive oxygen species, but recent research is suggestive the estrogen-like structures of soy isoflavones may contribute of additional antioxidant activity beyond direct scavenging to similar activities, such as regulating adipogenesis by of radicals. Genistein, in particular, has been shown to binding to estrogen receptors, thus decreasing lipoprotein activate transcription factors such as estrogen receptor lipase activity, and PPAR may also be involved in the and stimulate gene expression in breast cancer cells (38). regulation (24). Levels of genistein, a soy isoflavone, ranging By contrast, genistein inhibited androgen responsive gene from 0.1 to 1.0 µM have been shown to inhibit adipogenesis, expression (42). These results indicating that genistein may © AME Medical Journal. All rights reserved. amj.amegroups.com AME Med J 2017;2;162 AME Medical Journal, 2017 Page 3 of 9 Genistein Daidzein Glycitein Figure 1 Structure of genistein, daidzein, and glycitein. have broad ability to impact overall cellular homeostasis mediated pathways and induce a proliferative response in through a variety of
Load more

Recommended publications
  • Biologically Active Molecules from Soybeans
    10 Biologically Active Molecules from Soybeans Michio Kurosu Department of Pharmaceutical Sciences, University of Tennessee Health Science Center USA 1. Introduction Soybeans (Glycine max [L.] Merr.) contain an impressive array of biologically active components. People have been eating soybeans for almost 5,000 years. Unlike most plant foods, soybeans are high in protein. Researchers are interested in both the nutritional value and the potential health benefits of soybeans. Research of the health effects of soyfoods and soybean constituents has been received significant attention to support the health improvements or health risks observed clinically or in vitro experiments. This research includes a wide range of areas, such as cancer, coronary heart disease (cardiovascular disease), osteoporosis, cognitive function (memory related), menopausal symptoms, renal function, and many others. This chapter provides up-to-date coverage on biologically active and related organic molecules isolated from soy and soy products. Their biological activities are briefly summarized. Molecules discussed in this chapter are as follows: isoflavones, phytic acid, soy lipids, soy phytoalexins, soyasaponins, lectins, hemagglutinin, soy toxins, and vitamins. 2. Health benefit of soy or soy products Soy products have been considered as great source of protein for many decades. Japanese, in particular, eat a soy-based diet. Japanese monks eat soy products as their main protein source. They are known to live longer and have lower rates of chronic diseases. Because soybeans contain practically no starch, soybeans are an important part of a diabetic diet. Soybeans are 1) rich in protein (vide supra), calcium, and vitamins, and 2) high in mono- saturated fatty acids. In addition, soybeans contain several biologically interesting phytochemicals as minor components, which scientists are interested in understanding their biological functions.
    [Show full text]
  • Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia Phymatum Σ54 During Symbiosis with Phaseolus Vulgaris
    Research Collection Journal Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Author(s): Lardi, Martina; Liu, Yilei; Giudice, Gaetano; Ahrens, Christian H.; Zamboni, Nicola; Pessi, Gabriella Publication Date: 2018-04 Permanent Link: https://doi.org/10.3929/ethz-b-000258158 Originally published in: International Journal of Molecular Sciences 19(4), http://doi.org/10.3390/ijms19041049 Rights / License: Creative Commons Attribution 4.0 International This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library International Journal of Molecular Sciences Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Martina Lardi 1, Yilei Liu 1, Gaetano Giudice 1, Christian H. Ahrens 2, Nicola Zamboni 3 and Gabriella Pessi 1,* ID 1 Department of Plant and Microbial Biology, University of Zurich, CH-8057 Zurich, Switzerland; [email protected] (M.L.); [email protected] (Y.L.); [email protected] (G.G.) 2 Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics & Swiss Institute of Bioinformatics (SIB), CH-8820 Wädenswil, Switzerland; [email protected] 3 Institute of Molecular Systems Biology, ETH Zurich, CH-8093 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +41-44-6352904 Received: 28 February 2018; Accepted: 28 March 2018; Published: 1 April 2018 Abstract: RpoN (or σ54) is the key sigma factor for the regulation of transcription of nitrogen fixation genes in diazotrophic bacteria, which include α- and β-rhizobia.
    [Show full text]
  • The Pharmacologist 2 0 0 6 December
    Vol. 48 Number 4 The Pharmacologist 2 0 0 6 December 2006 YEAR IN REVIEW The Presidential Torch is passed from James E. Experimental Biology 2006 in San Francisco Barrett to Elaine Sanders-Bush ASPET Members attend the 15th World Congress in China Young Scientists at EB 2006 ASPET Awards Winners at EB 2006 Inside this Issue: ASPET Election Online EB ’07 Program Grid Neuropharmacology Division Mixer at SFN 2006 New England Chapter Meeting Summary SEPS Meeting Summary and Abstracts MAPS Meeting Summary and Abstracts Call for Late-Breaking Abstracts for EB‘07 A Publication of the American Society for 121 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The Editor PHARMACOLOGIST Suzie Thompson EDITORIAL ADVISORY BOARD Bryan F. Cox, Ph.D. News Ronald N. Hines, Ph.D. Terrence J. Monks, Ph.D. 2006 Year in Review page 123 COUNCIL . President Contributors for 2006 . page 124 Elaine Sanders-Bush, Ph.D. Election 2007 . President-Elect page 126 Kenneth P. Minneman, Ph.D. EB 2007 Program Grid . page 130 Past President James E. Barrett, Ph.D. Features Secretary/Treasurer Lynn Wecker, Ph.D. Secretary/Treasurer-Elect Journals . Annette E. Fleckenstein, Ph.D. page 132 Past Secretary/Treasurer Public Affairs & Government Relations . page 134 Patricia K. Sonsalla, Ph.D. Division News Councilors Bryan F. Cox, Ph.D. Division for Neuropharmacology . page 136 Ronald N. Hines, Ph.D. Centennial Update . Terrence J. Monks, Ph.D. page 137 Chair, Board of Publications Trustees Members in the News .
    [Show full text]
  • Phytoalexins: Current Progress and Future Prospects
    Phytoalexins: Current Progress and Future Prospects Edited by Philippe Jeandet Printed Edition of the Special Issue Published in Molecules www.mdpi.com/journal/molecules Philippe Jeandet (Ed.) Phytoalexins: Current Progress and Future Prospects This book is a reprint of the special issue that appeared in the online open access journal Molecules (ISSN 1420-3049) in 2014 (available at: http://www.mdpi.com/journal/molecules/special_issues/phytoalexins-progress). Guest Editor Philippe Jeandet Laboratory of Stress, Defenses and Plant Reproduction U.R.V.V.C., UPRES EA 4707, Faculty of Sciences, University of Reims, PO Box. 1039, 51687 Reims cedex 02, France Editorial Office MDPI AG Klybeckstrasse 64 Basel, Switzerland Publisher Shu-Kun Lin Managing Editor Ran Dang 1. Edition 2015 MDPI • Basel • Beijing ISBN 978-3-03842-059-0 © 2015 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons Attribution 3.0 license (http://creativecommons.org/licenses/by/3.0/), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, the dissemination and distribution of copies of this book as a whole is restricted to MDPI, Basel, Switzerland. III Table of Contents About the Editor ............................................................................................................... VII List of
    [Show full text]
  • ABSTRACT Title of Document: BIOLOGICAL
    ABSTRACT Title of Document: BIOLOGICAL EFFICACY, MECHANISMS OF ACTIONS OF SOY-DERIVED PHYTOALEXIN GLYCEOLLINS IN PREVENTION OF CHRONIC DISEASES Haiqiu Huang, Doctor of Philosophy, 2014 Directed By: Professor Liangli (Lucy) Yu Department of Nutrition and Food Science Cardiovascular disease (CVD) is the leading cause of deaths worldwide. Prostate cancer is the most prevalent cancer in U.S. male population. Diet-induced hypercholesterolemia and chronic inflammation promote the development of both CVD and prostate cancer. Glyceollins are a group of soy phytoalexins possessing a variety of biological activities. This research project focused on characterizing glyceollins’ bioactivities in alleviating cholesterol dysregulation, prevention of prostate cancer, and regulating gut microbiome. The first part of the project aimed to evaluate glyceollins’ cholesterol- lowering effect in-vivo. Male golden Syrian hamsters were fed high-fat diet with or without glyceollins supplementation for 28 days. Glyceollins supplementation led to a significant reduction of plasma VLDL, hepatic cholesterol esters and total lipid content. Consistent with changes in circulating cholesterol, glyceollins supplementation also altered expression of the genes related to cholesterol metabolism in the liver. The second part of the study aimed to evaluate glyceollins’ effect in reducing prostate cancer tumor growth in a xenograft model. An initial delayed appearance of tumor was observed in a PC-3 xenograft model. However, no difference in tumor sizes was observed in a LNCaP xenograft model. Extrapolation analysis of tumor measurements indicated that no difference in sizes was expected for both PC-3 and LNCaP tumors. Glyceollins had no effect on the androgen responsive pathway, its proliferation, cell cycle, or on angiogenesis genes in tumor and xenobiotic metabolism, cholesterol transport, and inflammatory cytokine genes in liver.
    [Show full text]
  • Appendix 1 – Protocol for Preventing Or Reversing Chronic Disease The
    Appendix 1 – Protocol for Preventing or Reversing Chronic Disease The first author has developed a protocol over the past decade for preventing or reversing chronic disease based on the following systemic medical principle: “at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective”[1]. The protocol methodology refines the age-old principles of both reducing harm in addition to providing treatment, and allows better identification of factors that contribute to the disease process (so that they may be eliminated if possible). These contributing factors are expansive and may include a combination of Lifestyle choices (diet, exercise, smoking), iatrogenic and biotoxin exposures, environmental/occupational exposures, and psychosocial stressors. This strategy exploits the existing literature to identify patterns of biologic response using biomarkers from various modalities of diagnostic testing to capture a much broader list of potential contributing factors. Existing inflammatory bowel diseases (IBD) Biomarker Identification to Remove Contributing Factors and Implement Treatment The initial protocol steps are diagnostic. The main output of these diagnostics will be identification of the biomarker levels and symptoms that reflect abnormalities, and the directions of change required to eliminate these abnormalities. In the present study, hundreds of general and specific biomarkers and symptoms were identified from the core IBD literature. The highest frequency (based on numbers of record appearances) biomarkers and symptoms were extracted, and are listed in Table 1 (highest frequency items first, reading down each column before proceeding to the next column). They are not necessarily consensus biomarkers. They are biomarkers whose values were altered by a treatment or contributing factor, and reported in the core IBD literature.
    [Show full text]
  • Gmmyb176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 6-28-2017 12:00 AM GmMYB176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean Arun Kumaran Anguraj Vadivel The University of Western Ontario Supervisor Dr. Sangeeta Dhaubhadel The University of Western Ontario Joint Supervisor Dr. Mark Bernards The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Arun Kumaran Anguraj Vadivel 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Molecular Biology Commons, and the Plant Biology Commons Recommended Citation Anguraj Vadivel, Arun Kumaran, "GmMYB176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean" (2017). Electronic Thesis and Dissertation Repository. 4639. https://ir.lib.uwo.ca/etd/4639 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. i Abstract MYB transcription factors are one of the largest transcription factor families characterized in plants. They are classified into four types: R1 MYB, R2R3 MYB, R3 MYB and R4 MYB. GmMYB176 is an R1MYB transcription factor that regulates Chalcone synthase (CHS8) gene expression and isoflavonoid biosynthesis in soybean. Silencing of GmMYB176 suppressed the expression of the GmCHS8 gene and reduced the accumulation of isoflavonoids in soybean hairy roots. However, overexpression of GmMYB176 does not alter either GmCHS8 gene expression or isoflavonoid levels suggesting that GmMYB176 alone is not sufficient for GmCHS8 gene regulation.
    [Show full text]
  • The Science of Flavonoids the Science of Flavonoids
    The Science of Flavonoids The Science of Flavonoids Edited by Erich Grotewold The Ohio State University Columbus, Ohio, USA Erich Grotewold Department of Cellular and Molecular Biology The Ohio State University Columbus, Ohio 43210 USA [email protected] The background of the cover corresponds to the accumulation of flavonols in the plasmodesmata of Arabidopsis root cells, as visualized with DBPA (provided by Dr. Wendy Peer). The structure corresponds to a model of the Arabidopsis F3 'H enzyme (provided by Dr. Brenda Winkel). The chemical structure corresponds to dihydrokaempferol. Library of Congress Control Number: 2005934296 ISBN-10: 0-387-28821-X ISBN-13: 978-0387-28821-5 ᭧2006 Springer ScienceϩBusiness Media, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer ScienceϩBusiness Media, Inc., 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed in the United States of America (BS/DH) 987654321 springeronline.com PREFACE There is no doubt that among the large number of natural products of plant origin, debatably called secondary metabolites because their importance to the eco- physiology of the organisms that accumulate them was not initially recognized, flavonoids play a central role.
    [Show full text]
  • Isoflavonoid Biosynthesis 21321.Pdf
    Isoflavonoid Biosynthesis https://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&map=map00943&keyword=flavonoids Isoflavonoids are biologically active compounds, such as phytoestrogens, produced by pea family plants. While flavonoids (in the narrow sense) have the 2- phenylchromen-4-one backbone, isoflavonoids have the 3-phenylchromen-4-one backbone with no hydroxyl group substitution at position 2. Isoflavonoids are derived from the flavonoid biosynthesis pathway via liquiritigenin or naringenin. (Flavonoid Biosynthesis) -> [1,2] 1) Liquiritigenin -> [1,2,3] 1) flavone synthesis I & II -> 7,4’Dihydroxyflavone OR 2) flavonoid 6-hydroxylase -> 6,7,4’-Trihydroxyflavanone -> 2- hydroxyisoflavone synthase -> 2,6,7,4’-tetrahydroxyisoflavanone -> 6- Hydroxydaidzein -> Glycitein -> isoflavone 7-O-glucosyltransferase -> Glycitein 7-O-glucoside -> isoflavone 7-O-glucoside-6’’-O-malonyltransferase -> Glycitein 7-O-glucoside-6”-O-malonate OR 3) 2-hydroxyisoflavanone synthase -> 2,7,4’Trihydroxyisoflavanone -> [1,2] 1) Feedback Loop 2,7,4’-trihydroxyisoflavanone 4’-O-methyltransferase / isoflavone 4’-O-methyltransferase -> 2,7-Dihydroxy-4’-methoxyisoflavanone -> 2- hydroxyisoflavanone dehydratase -> Formononetin OR 2) 2-hydroxyisoflavone dehydratase -> Daidzein -> [1,2,3,4,5] 1) isoflavone/4’-methoxyisoflavone 2’-hydroxylase -> 2’Hydroxydaidzein -> 2’Hydroxydaidzein reductase -> 2’-Hydroxydihydrodaidzein -> 3,9-Dihydroxypterocarpan -> 3,9-dihydroxypterocarpan 6a-monooxygenase -> 3,6,9- Trihydroxypterocarpan -> [1,2] 1) trihydroxypterocarpan dimethylallyltransferase
    [Show full text]
  • Molecular Pathways of Estrogen Receptor Action
    International Journal of Molecular Sciences Molecular Pathways of Estrogen Receptor Action Edited by Farzad Pakdel Printed Edition of the Special Issue Published in International Journal of Molecular Sciences www.mdpi.com/journal/ijms Molecular Pathways of Estrogen Receptor Action Molecular Pathways of Estrogen Receptor Action Special Issue Editor Farzad Pakdel MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Farzad Pakdel University of Rennes France Editorial Office MDPI St. Alban-Anlage 66 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal International Journal of Molecular Sciences (ISSN 1422-0067) from 2017 to 2018 (available at: https: //www.mdpi.com/journal/ijms/special issues/estrogen) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-296-9 (Pbk) ISBN 978-3-03897-297-6 (PDF) Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Contents About the Special Issue Editor ...................................... vii Farzad Pakdel Molecular Pathways of Estrogen Receptor Action Reprinted from: Int.
    [Show full text]
  • Identification and Characterization of the Isoflavonoid-Specific Prenyltransferase Gene Family to Prevent Stem and Root Rot in Soybean
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 9-30-2016 12:00 AM Identification and Characterization of the Isoflavonoid-Specific Prenyltransferase Gene Family to Prevent Stem and Root Rot in Soybean Arjun Sukumaran The University of Western Ontario Supervisor Dr. Sangeeta Dhaubhadel The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Arjun Sukumaran 2016 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Biology Commons, Genetics and Genomics Commons, Plant Biology Commons, and the Plant Pathology Commons Recommended Citation Sukumaran, Arjun, "Identification and Characterization of the Isoflavonoid-Specific Prenyltransferase Gene Family to Prevent Stem and Root Rot in Soybean" (2016). Electronic Thesis and Dissertation Repository. 4130. https://ir.lib.uwo.ca/etd/4130 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. i Abstract Soybean is one of the most predominantly grown legumes worldwide, however, one deterrent to maximizing its yield is the pathogen, Phytophthora sojae, which causes stem and root rot disease. Many strategies have been implemented to combat this pathogen such as use of pesticides and certain agricultural practices. However, these have been largely ineffective in completely preventing P. sojae infection. An alternative strategy would be to improve the innate resistance of soybean by promoting increased glyceollin production. Glyceollins are soybean-specific antimicrobial agents which are derived from the isoflavonoid branch of the general phenylpropanoid pathway.
    [Show full text]
  • Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis Virgilo A
    Cancer Therapy: Preclinical Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis Virgilo A. Salvo,1, 5 Stephen M. Boue¤ ,7 Juan P. Fonseca,1, 5 Steven Elliott,1, 6 Cynthia Corbitt,8 Bridgette M. Collins-Burow,1Tyler J. Curiel,1, 5 Sudesh K. Srivastav,4,5 Betty Y. Shih,7 Carol Carter-Wientjes,7 Charles E. Wood,9 Paul W. Erhardt,10 Barbara S. Beckman,3,5,6 John A. McLachlan,3,5,6 Thomas E. Cleveland,7 and Matthew E. Burow1, 2 , 3, 5, 6 Abstract Purpose: We have identified the phytoalexin compounds glyceollins I, II, and III, which exhibit marked antiestrogenic effects on estrogen receptor function and estrogen-dependent tumor growth in vivo. The purpose of this study was to investigate the interactions among the induced soy phytoalexins glyceollins I, II, and III on the growth of estrogen-dependent MCF-7 breast cancer and BG-1ovarian cancer cells implanted in ovariectomized athymic mice. Experimental Design: Four treatment groups for each cell line were used: vehicle control, 20 mg/kg/mouse/d glyceollin mixture injection, 0.72 mg estradiol (E2) implant, and E2 implant + 20 mg/kg/mouse/d glyceollin injection. Results:Treatment with glyceollin suppressed E2-stimulated tumor growth of MCF-7 cells (À53.4%) and BG-1cells (À73.1%) in ovariectomized athymic mice. These tumor-inhibiting effects corresponded with significantly lower E2-induced progesterone receptor expression in the tumors. In contrast to tamoxifen, the glyceollins had no estrogen-agonist effects on uterine morphology and partially antagonized the uterotropic effects of estrogen. Conclusions: These findings identify glyceollins as antiestrogenic agents that may be useful in the prevention or treatment of breast and ovarian carcinoma.
    [Show full text]